Results 91 to 100 of about 80,905 (244)

Does lipoprotein (a) level have a predictive value in restenosis after coronary stenting?

open access: yesInternational Journal of Preventive Medicine, 2011
Objectives: Lipid disorders, lipoproteins, diabetes mellitus, and hypertension are the known risk factors for coronary artery diseases; however, their role is unknown in restenosis after coronary stenting.
Alireza Khosravi   +5 more
doaj  

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction - (TOPCARE-AMI) [PDF]

open access: yes, 2002
Background - Experimental studies suggest that transplantation of blood-derived or bone marrow–derived progenitor cells beneficially affects postinfarction remodeling.
Aicher, A   +12 more
core   +1 more source

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)

open access: yesRevista Colombiana de Cardiología, 2012
Introducción y objetivos: los stents convencionales presentan tasas de restenosis intrastent entre 10% y 60%, mientras los stents liberadores de fármacos alcanzan el 10%. Para Latinoamérica, no hay reportes de restenosis intrastent en comparación con los
Jorge A Arroyave C, Magda C Cepeda G
doaj  

The effects of dextromethorphan on the outcome of percutaneous coronary intervention with bare-metal stent implantation

open access: yesJournal of Medical Sciences, 2018
Background: In the era of drug-eluting stents, although bare-metal stent (BMS) remains an option for percutaneous coronary intervention (PCI), restenosis remains the Achilles' heel of BMS implantation. A recent study demonstrated several pleiotropic anti-
Wen-Cheng Liu   +9 more
doaj   +1 more source

Percutaneous Ureteric Stricture Dilation (PCUSD) [PDF]

open access: yes, 1997
Ureteric stricture dilation as an interventional uroradiological technique was initiated locally in March 1991. In ureteric dilation two approaches are feasible.
Cutajar, Lino   +4 more
core  

Introduction. Carotid endarterectomy versus carotid stenting. A never-ending story [PDF]

open access: yes, 2018
L'articolo discute le controversie relative all'accettazione in pratica clinica dello stentig ...
de Donato, Gianmarco   +2 more
core   +1 more source

The Restenosis “Antitheory” [PDF]

open access: yesMayo Clinic Proceedings, 1993
Within the field of interventional cardiology, the foremost challenge is to find an effective treatment to prevent restenosis. In the United States, more than 400,000 patients underwent a percutaneous coronary intervention procedure in 1992; more than a third of these patients will have recur­ rence of luminal narrowing. Since the first angioplasty was
openaire   +2 more sources

Recurrent carotid artery stenosis successfully and safely treated with drug-coated balloon angioplasty under flow reversal

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques
Carotid artery restenosis after index carotid artery revascularization reduces its stroke prevention benefit. A 73-year-old woman presented with recurrent right carotid artery restenosis following two carotid endarterectomies with patch angioplasty and ...
Marianna Pavlyha, MD   +2 more
doaj   +1 more source

Propofol combined with bone marrow mesenchymal stem cell transplantation improves electrophysiological function in the hindlimb of rats with spinal cord injury better than monotherapy

open access: yesNeural Regeneration Research, 2015
The repair effects of bone marrow mesenchymal stem cell transplantation on nervous system damage are not satisfactory. Propofol has been shown to protect against spinal cord injury. Therefore, this study sought to explore the therapeutic effects of their
Yue-xin Wang   +6 more
doaj   +1 more source

Imaging in-stent restenosis: an inexpensive, reliable, and rapid preclinical model. [PDF]

open access: yes, 2009
Preclinical models of restenosis are essential to unravel the pathophysiological processes that lead to in-stent restenosis and to optimize existing and future drug-eluting stents. A variety of antibodies and transgenic and knockout strains are available
Deuse, Tobias   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy